RxSight, Inc.RXSTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.3%
5Y CAGR+32.4%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+21.3%/yr
Annual compound
5Y CAGR
+32.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$151.20M+11.3%
2024$135.80M+30.8%
2023$103.85M+22.7%
2022$84.65M+47.7%
2021$57.30M+54.4%
2020$37.11M-16.1%
2019$44.25M-